Association between systemic sclerosis and breast cancer: Eight new cases and review of the literature

Clinical Rheumatology

Volumn 23, Issue 6, 2004, Pages 516-522

  Launay, David ^a   Le Berre, Rozenn ^a   Hatron, Pierre Yves ^a   Peyrat, Jean Philippe ^b   Hachulla, Eric ^a   Devulder, Bernard ^a   Hebbar, Mohamed ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

Breast cancer; E selectin; Endothelial cells; Systemic sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; BOSENTAN; BUFLOMEDIL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; HYDROXYCHLOROQUINE; ILOPROST; NAVELBINE; NIFEDIPINE; PACLITAXEL; PENICILLAMINE; PREDNISOLONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DYSPNEA; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; LUNG FIBROSIS; LYMPH NODE METASTASIS; MASTECTOMY; MEDICAL RECORD; ONSET AGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIODENSITOMETRY; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SKIN DISEASE; SYSTEMIC SCLEROSIS;

EID: 9444272289     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0940-5     Document Type: Article

References (32)

1. LeRoy EC, Black C, Fleischmajer R, et al. (1988) Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15:202-205 1:STN:280:BieB3c%2FhsVQ%3D, 3361530
2. Fleischmajer R (1977) The pathophysiology of scleroderma. Int J Dermatol 16:321-328
3. Hill CL, Nguyen AM, Roder D, Roberts-Thomson P (2003) Risk of cancer in patients with scleroderma: A population based cohort study. Ann Rheum Dis 62:728-731 10.1136/ard.62.8.728, 1:STN:280:DC%2BD3szlsVSqtg%3D%3D, 12860727
4. Duncan SC, Winkelmann RK (1979) Cancer and scleroderma. Arch Dermatol 115:950-955 1:STN:280:CSaB3s%2Fjt1I%3D, 464624
5. Roumm AD, Medsger TA Jr (1985) Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 28:1336-1340 1:STN:280:BimC3czkvV0%3D, 4084328
6. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O (1995) Incidence of cancer among patients with systemic sclerosis. Cancer 76:910-914 1:STN:280:BymB38zht1Q%3D, 8625197
7. Rosenthal AK, McLaughlin JK, Linet MS, Persson I (1993) Scleroderma and malignancy: An epidemiological study. Ann Rheum Dis 52:531-533 1:STN:280:ByyA2cbhtlE%3D, 8346981
8. Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460-464 1:STN:280:ByyB3cjlsFc%3D, 8457221
9. Lee P, Alderdice C, Wilkinson S, Keystone EC, Urowitz MB, Gladman DD (1983) Malignancy in progressive systemic sclerosis, association with breast carcinoma. J Rheumatol 10:665-666 1:STN:280:BiuD3M%2FmslE%3D, 6312039
10. Masi AT, Rodnan GP, Medsger TA Jr, et al. (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581-590 7378088
11. Scarff RW, Torloni H (1968) Histological typing of breast tumors. International histological classification of tumors, no 2. World Health Organization, Geneva, pp 13-20
12. Talbott JH, Barrocas M (1979) Progressive systemic sclerosis (PSS) and malignancy, pulmonary and non-pulmonary. Medicine (Baltimore) 58:182-207
13. Forbes AM, Woodrow JC, Verbov JL, Graham RM (1989) Carcinoma of breast and scleroderma: Four further cases and a literature review. Br J Rheumatol 28:65-69 1:STN:280:BiaC3srktFA%3D, 2537127
14. Booton R, Jeffrey R, Prabhu PN (1999) Systemic sclerosis and scleroderma renal crisis in association with carcinoma of the breast. Am J Kidney Dis 34:937-941 1:STN:280:DC%2BD3c%2FjtVajuw%3D%3D, 10561153
15. Darras-Joly C, Wechsler B, Bletry O, Piette JC (1999) De novo systemic sclerosis after radiotherapy: A report of 3 cases. J Rheumatol 22:2265-2267
16. Bleasel NR, Stapleton KM, Commens C, Ahern VA (1999) Radiation-induced localized scleroderma in breast cancer patients. Australas J Dermatol 40:99-102 10.1046/j.1440-0960.1999.00330.x, 1:STN:280:DyaK1M3ms1Wltg%3D%3D, 10333622
17. Bielefeld P, Meyer P, Caillot D, et al. (1996) Systemic scleroderma and cancers: 21 cases and review of the literature (in French). Rev Med Interne 17:810-813 10.1016/0248-8663(96)82683-X, 1:STN:280:ByiC3s7jt1U%3D, 8976973
18. Hassett C, Harnett P, Manolios N (2001) Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 19:197-200 1:STN:280:DC%2BD3MvpsVKjsg%3D%3D, 11326485
19. Davies DA, Cohen PR, McNeese MD, Duvic M (1996) Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation. J Am Acad Dermatol 35:923-927 8959951
20. Ross JG, Hussey DH, Mayr NA, Davis CS (1993) Acute and late reactions to radiation in patients with collagen vascular diseases. Cancer 71:3744-3752 1:STN:280:ByyB2Mfns1U%3D, 8490925
21. Hesselstrand R, Scheja A, Akesson A (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57:682-686 1:STN:280:DyaK1M7itlartA%3D%3D, 9924211
22. Rattner JB, Rees J, Whitehead CM, et al. (1997) High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin Invest Med 20:308-319 1:STN:280:ByiH2sjnt1c%3D, 9336656
23. Kyndt X, Hebbar M, Queyrel V, Hachulla E, Hatron PY, Devulder B (1997) Systemic sclerosis and malignancy: Assessment of risk factors associated with the development of cancer in 123 patients with systemic sclerosis. Rev Med Interne 18:1-5
24. Derk CT, Sakkas LI, Rasheed M, Artlett C, Jimenez S (2003) Autoantibodies in patients with systemic sclerosis and cancer: A case-control study. J Rheumatol 30:1994-1996 1:CAS:528:DC%2BD3sXnvVSks7Y%3D, 12966604
25. Bevilacqua M, Pober J, Mendrick D, Cotran R, Gimbrone M (1987) Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A 84:9238-9242 1:CAS:528:DyaL1cXhtFSltLw%3D, 2827173
26. Hebbar M, Lassalle P, Janin A, et al. (1995) E-selectin expression in salivary endothelial cells and sera of patients with systemic sclerosis. Role of resident mast cell-derivated tumor necrosis factor alpha (TNF). Arthritis Rheum 38:406-412 1:STN:280:ByqC1crpt1Y%3D, 7533494
27. Claman H, Giorno RC, Seibold JR (1991) Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved" skin. Arthritis Rheum 34:1495-1501 1:STN:280:By2D1c3ltVE%3D, 1720957
28. Zetter B (1993) Adhesion molecules in tumor metastasis. Semin Cancer Biol 4:219-229 1:CAS:528:DyaK3sXmtVSks7Y%3D, 8400144
29. Recchi MA, Hebbar M, Hornez L, Harduin-Lepers A, Peyrat JP, Delannoy P (1998) Multiplex reverse transcriptase polymerase chain reaction assessment of sialyltransferases expression in human breast cancer. Cancer Res 58:4066-4070 1:CAS:528:DyaK1cXmtlCksro%3D, 9751611
30. Hebbar M, Révillion F, Louchez MM, Fournier C, Bonneterre J, Peyrat JP (1999) Prognostic value of circulating soluble E-Selectin in node-negative breast cancer patients. Clin Cancer Res 5:1427-1435 1:STN:280:DyaK1Mzhs1Oqsg%3D%3D, 10389928
31. Hebbar M, Révillion F, Louchez MM, et al. (1998) The relationship between concentrations of circulating soluble E-selectin and clinical, biological, and pathological features in patients with breast cancer. Clin Cancer Res 4:373-380 1:CAS:528:DyaK1cXhtlSmsb0%3D, 9516925
32. Hamada J, Cavanaugh PG, Lotan O (1994) Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer 66:349-354